{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:17:05Z","timestamp":1786979825260,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00228-019-02702-4","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:43:21Z","timestamp":1560213801000},"page":"1293-1307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mortality among patients due to adverse drug reactions that occur following hospitalisation: a meta-analysis"],"prefix":"10.1007","volume":"75","author":[{"given":"Parvati B.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8766-5632","authenticated-orcid":false,"given":"Tejas K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"issue":"6","key":"2702_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","volume":"73","author":"TJ Oscanoa","year":"2017","unstructured":"Oscanoa TJ, Lizaraso F, Carvajal A (2017) Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 73(6):759\u2013770","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"2702_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s40264-015-0281-0","volume":"38","author":"JC Bouvy","year":"2015","unstructured":"Bouvy JC, De Bruin ML, Koopmanschap MA (2015) Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf 38(5):437\u2013453","journal-title":"Drug Saf"},{"issue":"2","key":"2702_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1023\/A:1015570104121","volume":"24","author":"HJM Beijer","year":"2002","unstructured":"Beijer HJM, De Blaey CJ (2002) Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 24(2):46\u201354","journal-title":"Pharm World Sci"},{"issue":"7","key":"2702_CR4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1345\/aph.1L037","volume":"42","author":"C Kongkaew","year":"2008","unstructured":"Kongkaew C, Noyce PR, Ashcroft DM (2008) Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 42(7):1017\u20131025","journal-title":"Ann Pharmacother"},{"issue":"15","key":"2702_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN (1998) Prevalence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200\u20131205","journal-title":"JAMA"},{"issue":"6","key":"2702_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00228-018-2441-5","volume":"74","author":"TK Patel","year":"2018","unstructured":"Patel TK, Patel PB (2018) Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis. Eur J Clin Pharmacol 74(6):819\u2013832","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2702_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00228-016-2170-6","volume":"73","author":"NS Patel","year":"2017","unstructured":"Patel NS, Patel TK, Patel PB, Naik VN, Tripathi CB (2017) Hospitalizations due to preventable adverse reactions-a systematic review. Eur J Clin Pharmacol 73(4):385\u2013398","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"2702_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40264-016-0444-7","volume":"39","author":"MT Angamo","year":"2016","unstructured":"Angamo MT, Chalmers L, Curtain CM, Bereznicki LR (2016) Adverse-drug-reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf 39(9):847\u2013857","journal-title":"Drug Saf"},{"issue":"2","key":"2702_CR9","doi-asserted-by":"publisher","first-page":"e4439","DOI":"10.1371\/journal.pone.0004439","volume":"4","author":"EC Davies","year":"2009","unstructured":"Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 4(2):e4439","journal-title":"PLoS One"},{"issue":"12","key":"2702_CR10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1345\/aph.10094","volume":"34","author":"DC Suh","year":"2000","unstructured":"Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER (2000) Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 34(12):1373\u20131379","journal-title":"Ann Pharmacother"},{"issue":"11","key":"2702_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/pds.3309","volume":"21","author":"A Miguel","year":"2012","unstructured":"Miguel A, Azevedo LF, Ara\u00fajo M, Pereira AC (2012) Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 21(11):1139\u20131154","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"2702_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1574886310666150921104523","volume":"11","author":"TK Patel","year":"2016","unstructured":"Patel TK, Patel PB (2016) Incidence of adverse drug reactions in Indian hospitals: a systematic review of prospective studies. Curr Drug Saf 11(2):128\u2013136","journal-title":"Curr Drug Saf"},{"issue":"6","key":"2702_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00228-016-2026-0","volume":"72","author":"AJ Pardo Cabello","year":"2016","unstructured":"Pardo Cabello AJ, Del Pozo Gavil\u00e1n E, G\u00f3mez Jim\u00e9nez FJ, Mota Rodr\u00edguez C, Luna Del Castillo Jde D, Puche Ca\u00f1as E (2016) Drug-related mortality among inpatients: a retrospective observational study. Eur J Clin Pharmacol 72(6):731\u2013736","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2702_CR14","doi-asserted-by":"publisher","first-page":"e24061","DOI":"10.1371\/journal.pone.0024061","volume":"7","author":"RMD Smyth","year":"2012","unstructured":"Smyth RMD, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R et al (2012) Adverse drug reactions in children\u2014a systematic review. PLoS One 7(3):e24061","journal-title":"PLoS One"},{"issue":"11","key":"2702_CR15","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T (2013) Meta-analysis of prevalence. J Epidemiol Community Health 67(11):974\u2013978","journal-title":"J Epidemiol Community Health"},{"issue":"7414","key":"2702_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"issue":"6","key":"2702_CR17","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/intqhc\/mzt075","volume":"25","author":"H Aljadhey","year":"2013","unstructured":"Aljadhey H, Mahmoud MA, Mayet A, Alshaikh M, Ahmed Y, Murray MD et al (2013) Incidence of adverse drug events in an academic hospital: a prospective cohort study. Int J Qual Health Care 25(6):648\u2013655","journal-title":"Int J Qual Health Care"},{"issue":"7","key":"2702_CR18","doi-asserted-by":"publisher","first-page":"e010831","DOI":"10.1136\/bmjopen-2015-010831","volume":"6","author":"H Aljadhey","year":"2016","unstructured":"Aljadhey H, Mahmoud MA, Ahmed Y, Sultana R, Zouein S, Alshanawani S et al (2016) Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study. BMJ Open 6(7):e010831","journal-title":"BMJ Open"},{"issue":"4","key":"2702_CR19","first-page":"442","volume":"44","author":"M Alsbou","year":"2010","unstructured":"Alsbou M (2010) Incidence of adverse drug reactions in Alkarak hospital: a pilot study. J Med J 44(4):442\u2013446","journal-title":"J Med J"},{"issue":"8","key":"2702_CR20","doi-asserted-by":"publisher","first-page":"e0182327","DOI":"10.1371\/journal.pone.0182327","volume":"12","author":"PHS Andrade","year":"2017","unstructured":"Andrade PHS, Lobo IMF, da Silva WB (2017) Risk factors for adverse drug reactions in pediatric inpatients: a cohort study. PLoS One 12(8):e0182327","journal-title":"PLoS One"},{"issue":"4","key":"2702_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/archdischild-2015-309396","volume":"101","author":"A Bel\u00e9n Rivas","year":"2016","unstructured":"Bel\u00e9n Rivas A, Arruza L, Pacheco E, Portoles A, Diz J, Vargas E (2016) Adverse drug reactions in neonates: a prospective study. Arch Dis Child 101(4):371\u2013376","journal-title":"Arch Dis Child"},{"issue":"1","key":"2702_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/PTS.0b013e3181990d51","volume":"5","author":"RR Benkirane","year":"2009","unstructured":"Benkirane RR, Abouqal R, Haimeur CC, Ech Cherif S, El Kettani SS, Azzouzi AA, Mdaghri Alaoui AA et al (2009) Incidence of adverse drug events and medication errors in intensive care units: a prospective multicenter study. J Patient Saf 5(1):16\u201322","journal-title":"J Patient Saf"},{"issue":"4","key":"2702_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.2042-7174.2010.00039.x","volume":"18","author":"C Calder\u00f3n-Ospina","year":"2010","unstructured":"Calder\u00f3n-Ospina C, Bustamante-Rojas C (2010) The DoTS classification is a useful way to classify adverse drug reactions: a preliminary study in hospitalized patients. Int J Pharm Pract 18(4):230\u2013235","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"2702_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2710.2006.00744.x","volume":"31","author":"EC Davies","year":"2006","unstructured":"Davies EC, Green CF, Mottram DR, Pirmohamed M (2006) Adverse drug reactions in hospital in-patients: a pilot study. J Clin Pharm Ther 31(4):335\u2013341","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"2702_CR25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.25100\/cm.v47i3.2184","volume":"47","author":"R de Las Salas","year":"2016","unstructured":"de Las Salas R, D\u00edaz-Agudelo D, Burgos-Fl\u00f3rez FJ, Vaca C, Serrano-Meri\u00f1o DV (2016) Adverse drug reactions in hospitalized Colombian children. Colomb Med (Cali) 47(3):142\u2013147","journal-title":"Colomb Med (Cali)"},{"issue":"7","key":"2702_CR26","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jsps.2017.01.005","volume":"25","author":"AD de Oliveira-Filho","year":"2017","unstructured":"de Oliveira-Filho AD, Vieira AES, da Silva RC, Neves SJF, Gama TAB, Lima RV et al (2017) Adverse drug reactions in high-risk pregnant women: a prospective study. Saudi Pharm J 25(7):1073\u20131077","journal-title":"Saudi Pharm J"},{"key":"2702_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12887-016-0619-5","volume":"16","author":"MG Dedefo","year":"2016","unstructured":"Dedefo MG, Mitike AH, Angamo MT (2016) Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia. BMC Pediatr 16:81","journal-title":"BMC Pediatr"},{"issue":"4","key":"2702_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4103\/0976-500X.103687","volume":"3","author":"MS Doshi","year":"2012","unstructured":"Doshi MS, Patel PP, Shah SP, Dikshit RK (2012) Intensive monitoring of adverse drug reactions in hospitalized patients of two medical units at a tertiary care teaching hospital. J Pharmacol Pharmacother 3(4):308\u2013313","journal-title":"J Pharmacol Pharmacother"},{"issue":"13","key":"2702_CR29","first-page":"5","volume":"3","author":"HA El Sebaee","year":"2013","unstructured":"El Sebaee HA, El Salam Seloma YA (2013) Adverse drug reactions among critically ill patients at Cairo University Hospital: frequency and outcomes. J Biol Agr Healthc 3(13):5\u201313","journal-title":"J Biol Agr Healthc"},{"issue":"11","key":"2702_CR30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1177\/0091270005281205","volume":"45","author":"F Fattahi","year":"2005","unstructured":"Fattahi F, Pourpak Z, Moin M, Kazemnejad A, Khotaei GT, Mamishi S et al (2005) Adverse drug reactions in hospitalized children in a department of infectious diseases. J Clin Pharmacol 45(11):1313\u20131318","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"2702_CR31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1365-2125.2000.00132.x","volume":"49","author":"K Fattinger","year":"2000","unstructured":"Fattinger K, Roos M, Verg\u00e8res P, Holenstein C, Kind B, Masche U et al (2000) Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 49(2):158\u2013167","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2702_CR32","first-page":"154","volume":"18","author":"M Ganeva","year":"2016","unstructured":"Ganeva M, Gancheva T, Troeva J, Gancheva D, Hristakieva E (2016) A study of adverse drug reactions in hospitalized patients in relation to age. Eur J Clin Pharm 18(3):154\u2013162","journal-title":"Eur J Clin Pharm"},{"key":"2702_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.vascn.2016.04.011","volume":"81","author":"MI Geer","year":"2016","unstructured":"Geer MI, Koul PA, Tanki SA, Shah MY (2016) Frequency, types, severity, preventability and costs of adverse drug reactions at a tertiary care hospital. J Pharmacol Toxicol Methods 81:323\u2013334","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"1","key":"2702_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0253-7613.40488","volume":"40","author":"AP Gor","year":"2008","unstructured":"Gor AP, Desai SV (2008) Adverse drug reactions (ADR) in the in patients of Medicine Department of a Rural Tertiary Care Teaching Hospital and influence of pharmacovigilance in reporting ADR. Indian J Pharmacol 40(1):37\u201340","journal-title":"Indian J Pharmacol"},{"issue":"5","key":"2702_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2165\/00002018-200528050-00008","volume":"28","author":"S Haffner","year":"2005","unstructured":"Haffner S, von Laue N, Wirth S, Th\u00fcrmann PA (2005) Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values. Drug Saf 28(5):453\u2013464","journal-title":"Drug Saf"},{"issue":"1","key":"2702_CR36","first-page":"39","volume":"23","author":"DB Haile","year":"2013","unstructured":"Haile DB, Ayen WY, Tiwari P (2013) Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India. Ethiop J Health Sci 23(1):39\u201348","journal-title":"Ethiop J Health Sci"},{"issue":"3\u20134","key":"2702_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/jocn.12714","volume":"24","author":"M H\u00e4rk\u00e4nen","year":"2015","unstructured":"H\u00e4rk\u00e4nen M, Kervinen M, Ahonen J, Voutilainen A, Turunen H, Vehvil\u00e4inen-Julkunen K (2015) Patient-specific risk factors of adverse drug events in adult inpatients - evidence detected using the global trigger tool method. J Clin Nurs 24(3\u20134):582\u2013591","journal-title":"J Clin Nurs"},{"issue":"3","key":"2702_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0022-3859.85201","volume":"57","author":"A Harugeri","year":"2011","unstructured":"Harugeri A, Parthasarathi G, Ramesh M, Guido S, Basavanagowdappa H (2011) Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals. J Postgrad Med 57(3):189\u2013195","journal-title":"J Postgrad Med"},{"issue":"1","key":"2702_CR39","first-page":"160","volume":"5","author":"JM Kathiria","year":"2013","unstructured":"Kathiria JM, Sattigeri BM, Desai PM, Patel SP (2013) A study of adverse drug reactions in patients admitted to intensive care unit of a tertiary care teaching rural hospital. Int J Pharm Pharm Sci 5(1):160\u2013163","journal-title":"Int J Pharm Pharm Sci"},{"issue":"1","key":"2702_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0253-7613.75661","volume":"43","author":"S Kaur","year":"2011","unstructured":"Kaur S, Kapoor V, Mahajan R, Lal M, Gupta S (2011) Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease. Indian J Pharmacol 43(1):22\u201326","journal-title":"Indian J Pharmacol"},{"issue":"1","key":"2702_CR41","doi-asserted-by":"publisher","first-page":"e010568","DOI":"10.1136\/bmjopen-2015-010568","volume":"7","author":"R Kiguba","year":"2017","unstructured":"Kiguba R, Karamagi C, Bird SM (2017) Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients. BMJ Open 7(1):e010568","journal-title":"BMJ Open"},{"issue":"8","key":"2702_CR42","doi-asserted-by":"publisher","first-page":"e71045","DOI":"10.1371\/journal.pone.0071045","volume":"8","author":"JE Klopotowska","year":"2013","unstructured":"Klopotowska JE, Wierenga PC, Stuijt CC, Arisz L, Dijkgraaf MG, Kuks PF et al (2013) Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy. PLoS One 8(8):e71045","journal-title":"PLoS One"},{"issue":"6","key":"2702_CR43","first-page":"1351","volume":"15","author":"Z Kourorian","year":"2009","unstructured":"Kourorian Z, Fattahi F, Pourpak Z, Rasoolinejad M, Gholami K (2009) Adverse drug reactions in an Iranian department of adult infectious diseases. East Mediterr Health J 15(6):1351\u20131357","journal-title":"East Mediterr Health J"},{"issue":"6","key":"2702_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/bcpt.12435","volume":"117","author":"O Lapatto-Reiniluoto","year":"2015","unstructured":"Lapatto-Reiniluoto O, Patinen L, Niemi M, Backman JT, Neuvonen PJ (2015) Drug-related inadvertent deaths in a university hospital--a declining trend. Basic Clin Pharmacol Toxicol 117(6):421\u2013426","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"2702_CR45","first-page":"32","volume":"6","author":"M Mandha","year":"2013","unstructured":"Mandha M, Reddy KP, Reddy KP (2013) Evaluation of adverse drug reactions in pediatric patients. Indian J Pharm P 6(3):32\u201335","journal-title":"Indian J Pharm P"},{"issue":"3","key":"2702_CR46","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2125.2007.03034.x","volume":"65","author":"U Mehta","year":"2008","unstructured":"Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI (2008) Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV\/AIDS prevalence: prospective observational study. Br J Clin Pharmacol 65(3):396\u2013406","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2702_CR47","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/bcp.13471","volume":"84","author":"E Montan\u00e9","year":"2018","unstructured":"Montan\u00e9 E, Arellano AL, Sanz Y, Roca J, Farr\u00e9 M (2018) Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol 84(3):542\u2013552","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"2702_CR48","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1001\/archinte.165.10.1111","volume":"165","author":"JR Nebeker","year":"2005","unstructured":"Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF (2005) High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 165(10):1111\u20131116","journal-title":"Arch Intern Med"},{"issue":"1","key":"2702_CR49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjopharm.2006.03.002","volume":"4","author":"JK Nguyen","year":"2006","unstructured":"Nguyen JK, Fouts MM, Kotabe SE, Lo E (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4(1):36\u201341","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"2702_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S1516-31802011000300006","volume":"129","author":"KA Oshikoya","year":"2011","unstructured":"Oshikoya KA, Chukwura H, Njokanma OF, Senbanjo IO, Ojo I (2011) Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria. Sao Paulo Med J 129(3):153\u2013164","journal-title":"Sao Paulo Med J"},{"issue":"1","key":"2702_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00228-012-1318-2","volume":"69","author":"S Park","year":"2013","unstructured":"Park S, In Y, Suh GY, Sohn K, Kim E (2013) Evaluation of adverse drug reactions in medical intensive care units. Eur J Clin Pharmacol 69(1):119\u2013131","journal-title":"Eur J Clin Pharmacol"},{"key":"2702_CR52","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s40267-015-0231-z","volume":"31","author":"N Patel","year":"2015","unstructured":"Patel N, Desai S (2015) Profile of adverse drug reactions in patients admitted to general surgical wards of a rural tertiary-care hospital in India. Drugs Ther Perspect 31:402\u2013406","journal-title":"Drugs Ther Perspect"},{"issue":"2","key":"2702_CR53","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1574886311666160225150106","volume":"11","author":"JV Peter","year":"2016","unstructured":"Peter JV, Varghese GH, Alexander H, Tom NR, Swethalekshmi V, Truman C et al (2016) Patterns of adverse drug reaction in the medical wards of a teaching hospital: a prospective observational cohort study. Curr Drug Saf 11(2):164\u2013171","journal-title":"Curr Drug Saf"},{"issue":"8","key":"2702_CR54","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1097\/01.CCM.0000171609.91035.BD","volume":"33","author":"JM Rothschild","year":"2005","unstructured":"Rothschild JM, Landrigan CP, Cronin JW, Kaushal R, Lockley SW, Burdick E et al (2005) The critical care safety study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 33(8):1694\u20131700","journal-title":"Crit Care Med"},{"issue":"1","key":"2702_CR55","first-page":"33","volume":"9","author":"P Sivasankaran","year":"2016","unstructured":"Sivasankaran P, Gupta M, Satyanarayan RB, Durai R (2016) Pattern of adverse drug reactions in a govt. district headquarters hospital in Tamilnadu, India. Indian J Pharm P 9(1):33\u201336","journal-title":"Indian J Pharm P"},{"issue":"8","key":"2702_CR56","first-page":"669","volume":"29","author":"B Tangiisuran","year":"2012","unstructured":"Tangiisuran B, Davies JG, Wright JE, Rajkumar C (2012) Adverse drug reactions in a population of hospitalized very elderly patients. Drugs Aging 29(8):669\u2013679","journal-title":"Drugs Aging"},{"key":"2702_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1741-7015-11-237","volume":"11","author":"S Thiesen","year":"2013","unstructured":"Thiesen S, Conroy EJ, Bellis JR, Bracken LE, Mannix HL, Bird KA et al (2013) Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC Med 11:237","journal-title":"BMC Med"},{"issue":"10","key":"2702_CR58","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/00002018-200225100-00004","volume":"25","author":"PA Thuermann","year":"2002","unstructured":"Thuermann PA, Windecker R, Steffen J, Schaefer M, Tenter U, Reese E et al (2002) Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach. Drug Saf 25(10):713\u2013724","journal-title":"Drug Saf"},{"issue":"1","key":"2702_CR59","first-page":"72","volume":"11","author":"WA Tumwikirize","year":"2011","unstructured":"Tumwikirize WA, Ogwal-Okeng JW, Vernby A, Anokbonggo WW, Gustafsson LL, Lundborg SC (2011) Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci 11(1):72\u201378","journal-title":"Afr Health Sci"},{"issue":"9","key":"2702_CR60","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2165\/00002018-200831090-00007","volume":"31","author":"Y Zopf","year":"2008","unstructured":"Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H (2008) Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf 31(9):789\u2013798","journal-title":"Drug Saf"},{"issue":"5","key":"2702_CR61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s002280000158","volume":"56","author":"M Zoppi","year":"2000","unstructured":"Zoppi M, Braunschweig S, Kuenzi UP, Maibach R, Hoign\u00e9 R (2000) Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne\/St. Gallen. Eur J Clin Pharmacol 56(5):427\u2013430","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2702_CR62","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/bcp.12567","volume":"80","author":"JP Mouton","year":"2015","unstructured":"Mouton JP, Mehta U, Parrish AG, Wilson DP, Stewart A, Njuguna CW et al (2015) Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey. Br J Clin Pharmacol 80(4):818\u2013826","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2702_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1310\/hpj5001-5","volume":"50","author":"J Generali","year":"2015","unstructured":"Generali J (2015) Critical care series. Hosp Pharm 50(1):5\u20136","journal-title":"Hosp Pharm"},{"issue":"4","key":"2702_CR64","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00228-011-1138-9","volume":"68","author":"P Devi","year":"2012","unstructured":"Devi P, Kamath DY, Anthony N, Santosh S, Dias B (2012) Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital. Eur J Clin Pharmacol 68(4):427\u2013433","journal-title":"Eur J Clin Pharmacol"},{"key":"2702_CR65","first-page":"2079","volume":"9","author":"TM Alhawassi","year":"2014","unstructured":"Alhawassi TM, Krass I, Bajorek BV, Pont LG (2014) A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 9:2079\u20132086","journal-title":"Clin Interv Aging"},{"issue":"2","key":"2702_CR66","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.12293","volume":"78","author":"A Al Hamid","year":"2014","unstructured":"Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z (2014) A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol 78(2):202\u2013217","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"2702_CR67","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00228-017-2330-3","volume":"73","author":"O Laatikainen","year":"2017","unstructured":"Laatikainen O, Miettunen J, Sneck S, Lehtiniemi H, Tenhunen O, Turpeinen M (2017) The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis. Eur J Clin Pharmacol 73(12):1539\u20131549","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"2702_CR68","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","volume":"35","author":"M Shoeb","year":"2013","unstructured":"Shoeb M, Fang MC (2013) Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis 35(3):312\u2013319","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"2702_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2141.2005.05953.x","volume":"133","author":"T Baglin","year":"2006","unstructured":"Baglin T, Barrowcliffe TW, Cohen A, Greaves M, British Committee for Standards in Haematology (2006) Guidelines on the use and monitoring of heparin. Br J Haematol 133(1):19\u201334","journal-title":"Br J Haematol"},{"issue":"1","key":"2702_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/bjh.12107","volume":"160","author":"M Makris","year":"2013","unstructured":"Makris M, Van Veen JJ, Tait CR, Mumford AD, Laffan M, British Committee for Standards in Haematology (2013) Guideline on the management of bleeding in patients on antithrombotic agents. Br J Haematol 160(1):35\u201346","journal-title":"Br J Haematol"},{"key":"2702_CR71","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-230X-9-41","volume":"9","author":"S Straube","year":"2009","unstructured":"Straube S, Tram\u00e8r MR, Moore RA, Derry S, McQuay HJ (2009) Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol 9:41","journal-title":"BMC Gastroenterol"},{"issue":"Suppl 3","key":"2702_CR72","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar4175","volume":"15","author":"C Sostres","year":"2013","unstructured":"Sostres C, Gargallo CJ, Lanas A (2013) Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther 15(Suppl 3):S3","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"2702_CR73","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1378\/chest.125.5.1616","volume":"125","author":"C Macie","year":"2004","unstructured":"Macie C, Forbes L, Foster GA, Douketis JD (2004) Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndrome. Chest 125(5):1616\u20131621","journal-title":"Chest"},{"issue":"3","key":"2702_CR74","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00228-012-1386-3","volume":"69","author":"FJ de Abajo","year":"2013","unstructured":"de Abajo FJ, Gil MJ, Bryant V, Timoner J, Oliva B, Garc\u00eda-Rodr\u00edguez LA (2013) Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol 69(3):691\u2013701","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"2702_CR75","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/jama.2015.0809","volume":"313","author":"AM Schjerning Olsen","year":"2015","unstructured":"Schjerning Olsen AM, Gislason GH, McGettigan P, Fosb\u00f8l E, S\u00f8rensen R, Hansen ML et al (2015) Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction. JAMA 313(8):805\u2013814","journal-title":"JAMA"},{"issue":"10","key":"2702_CR76","doi-asserted-by":"publisher","first-page":"690","DOI":"10.7326\/M13-1581","volume":"161","author":"M Lamberts","year":"2014","unstructured":"Lamberts M, Lip GY, Hansen ML, Lindhardsen J, Olesen JB, Rauns\u00f8 J et al (2014) Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. Ann Intern Med 161(10):690\u2013698","journal-title":"Ann Intern Med"},{"issue":"8","key":"2702_CR77","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/apt.13367","volume":"42","author":"D Shalman","year":"2015","unstructured":"Shalman D, Gerson LB (2015) Systematic review with meta-analysis: the risk of gastrointestinal haemorrhage post-polypectomy in patients receiving anti-platelet, anti-coagulant and\/or thienopyridine medications. Aliment Pharmacol Ther 42(8):949\u2013956","journal-title":"Aliment Pharmacol Ther"},{"key":"2702_CR78","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2017.11.005","volume":"120","author":"Y Lalami","year":"2017","unstructured":"Lalami Y, Klastersky J (2017) Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: an overview about well-established and recently emerging clinical data. Crit Rev Oncol Hematol 120:163\u2013179","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2702_CR79","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00280-010-1487-6","volume":"68","author":"K Shitara","year":"2011","unstructured":"Shitara K, Matsuo K, Oze I, Mizota A, Kondo C, Nomura M et al (2011) Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy. Cancer Chemother Pharmacol 68(2):301\u2013307","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"2702_CR80","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/14737140.2017.1380521","volume":"17","author":"X Tan","year":"2017","unstructured":"Tan X, Wen Q, Wang R, Chen Z (2017) Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies. Expert Rev Anticancer Ther 17(11):1077\u20131085","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"2702_CR81","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/dkt477","volume":"69","author":"C Slimings","year":"2014","unstructured":"Slimings C, Riley TV (2014) Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 69(4):881\u2013891","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2702_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkw385","volume":"72","author":"MH Wilcox","year":"2017","unstructured":"Wilcox MH, Chalmers JD, Nord CE, Freeman J, Bouza E (2017) Role of cephalosporins in the era of Clostridium difficile infection. J Antimicrob Chemother 72(1):1\u201318","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2702_CR83","first-page":"23","volume":"3","author":"P Spigaglia","year":"2016","unstructured":"Spigaglia P (2016) Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection. Ther Adv Infect Dis 3(1):23\u201342","journal-title":"Ther Adv Infect Dis"},{"issue":"2","key":"2702_CR84","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jac\/dkx413","volume":"73","author":"A Patton","year":"2018","unstructured":"Patton A, Davey P, Harbarth S, Nathwani D, Sneddon J, Marwick CA (2018) Impact of antimicrobial stewardship interventions on Clostridium difficile infection and clinical outcomes: segmented regression analyses. J Antimicrob Chemother 73(2):517\u2013526","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"2702_CR85","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3109\/0886022X.2014.917560","volume":"36","author":"X Wu","year":"2014","unstructured":"Wu X, Zhang W, Ren H, Chen X, Xie J, Chen N (2014) Diuretics associated acute kidney injury: clinical and pathological analysis. Ren Fail 36(7):1051\u20131055","journal-title":"Ren Fail"},{"issue":"1","key":"2702_CR86","first-page":"60","volume":"9","author":"SM Bagshaw","year":"2007","unstructured":"Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R (2007) Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 9(1):60\u201368","journal-title":"Crit Care Resusc"},{"issue":"7","key":"2702_CR87","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/emj.2006.038513","volume":"23","author":"A Davis","year":"2006","unstructured":"Davis A, Gooch I (2006) Best evidence topic report. The use of loop diuretics in acute renal failure in critically ill patients to reduce mortality, maintain renal function, or avoid the requirements for renal support. Emerg Med J 23(7):569\u2013570","journal-title":"Emerg Med J"},{"issue":"1","key":"2702_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1053\/j.ackd.2012.09.005","volume":"20","author":"AC Nadeau-Fredette","year":"2013","unstructured":"Nadeau-Fredette AC, Bouchard J (2013) Fluid management and use of diuretics in acute kidney injury. Adv Chronic Kidney Dis 20(1):45\u201355","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"2702_CR89","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/qjmed\/hcp143","volume":"102","author":"NM Selby","year":"2009","unstructured":"Selby NM, Shaw S, Woodier N, Fluck RJ, Kolhe NV (2009) Gentamicin-associated acute kidney injury. QJM 102(12):873\u2013880","journal-title":"QJM"},{"issue":"5","key":"2702_CR90","doi-asserted-by":"publisher","first-page":"100","DOI":"10.21037\/atm.2017.03.06","volume":"5","author":"W Srisung","year":"2017","unstructured":"Srisung W, Teerakanok J, Tantrachoti P, Karukote A, Nugent K (2017) Surgical prophylaxis with gentamicin and acute kidney injury: a systematic review and meta-analysis. Ann Transl Med 5(5):100","journal-title":"Ann Transl Med"},{"issue":"3","key":"2702_CR91","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/0971-4065.70839","volume":"20","author":"S Nayak-Rao","year":"2010","unstructured":"Nayak-Rao S (2010) Aminoglycoside use in renal failure. Indian J Nephrol 20(3):121\u2013124","journal-title":"Indian J Nephrol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02702-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02702-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02702-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T19:07:18Z","timestamp":1591729638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02702-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2702"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02702-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"10 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}